These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by Ye X; Huang D; Dong Z; Wang X; Ning M; Xia J; Shen S; Wu S; Shi Y; Wang J; Wan X Microbiol Spectr; 2022 Oct; 10(5):e0051822. PubMed ID: 36036629 [TBL] [Abstract][Full Text] [Related]
6. Liver fatty-acid-binding protein (L-FABP) gene ablation alters liver bile acid metabolism in male mice. Martin GG; Atshaves BP; McIntosh AL; Mackie JT; Kier AB; Schroeder F Biochem J; 2005 Nov; 391(Pt 3):549-60. PubMed ID: 15984932 [TBL] [Abstract][Full Text] [Related]
7. Liver fatty acid binding protein gene ablation potentiates hepatic cholesterol accumulation in cholesterol-fed female mice. Martin GG; Atshaves BP; McIntosh AL; Mackie JT; Kier AB; Schroeder F Am J Physiol Gastrointest Liver Physiol; 2006 Jan; 290(1):G36-48. PubMed ID: 16123197 [TBL] [Abstract][Full Text] [Related]
8. Diet-induced alterations in intestinal and extrahepatic lipid metabolism in liver fatty acid binding protein knockout mice. Newberry EP; Kennedy SM; Xie Y; Luo J; Davidson NO Mol Cell Biochem; 2009 Jun; 326(1-2):79-86. PubMed ID: 19116776 [TBL] [Abstract][Full Text] [Related]
9. Hypothyroidism Increases Cholesterol Gallstone Prevalence in Mice by Elevated Hydrophobicity of Primary Bile Acids. Kube I; Tardio LB; Hofmann U; Ghallab A; Hengstler JG; Führer D; Zwanziger D Thyroid; 2021 Jun; 31(6):973-984. PubMed ID: 33231505 [No Abstract] [Full Text] [Related]
10. Activation of the Hypoxia Inducible Factor 1α Subunit Pathway in Steatotic Liver Contributes to Formation of Cholesterol Gallstones. Asai Y; Yamada T; Tsukita S; Takahashi K; Maekawa M; Honma M; Ikeda M; Murakami K; Munakata Y; Shirai Y; Kodama S; Sugisawa T; Chiba Y; Kondo Y; Kaneko K; Uno K; Sawada S; Imai J; Nakamura Y; Yamaguchi H; Tanaka K; Sasano H; Mano N; Ueno Y; Shimosegawa T; Katagiri H Gastroenterology; 2017 May; 152(6):1521-1535.e8. PubMed ID: 28088462 [TBL] [Abstract][Full Text] [Related]
11. Peroxisome Proliferator-Activated Receptor- Wang G; Han T; Wang S; Chen M; Sun Y; Fu Z Biomed Res Int; 2018; 2018():7475626. PubMed ID: 30105244 [TBL] [Abstract][Full Text] [Related]
12. Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice. Newberry EP; Xie Y; Kennedy SM; Luo J; Davidson NO Hepatology; 2006 Nov; 44(5):1191-205. PubMed ID: 17058218 [TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibition protects against diet-induced gallstone formation through modulation of cholesterol and bile acid homeostasis. Lee EJ; Kim MH; Kim YR; Park JW; Park WJ Int J Mol Med; 2018 Mar; 41(3):1715-1723. PubMed ID: 29286073 [TBL] [Abstract][Full Text] [Related]
14. The effect of Tauroursodeoxycholic acid (TUDCA) and gut microbiota on murine gallbladder stone formation. Lu Q; Jiang Z; Wang Q; Hu H; Zhao G Ann Hepatol; 2021; 23():100289. PubMed ID: 33217585 [TBL] [Abstract][Full Text] [Related]
15. Ablating L-FABP in SCP-2/SCP-x null mice impairs bile acid metabolism and biliary HDL-cholesterol secretion. Martin GG; Atshaves BP; Landrock KK; Landrock D; Storey SM; Howles PN; Kier AB; Schroeder F Am J Physiol Gastrointest Liver Physiol; 2014 Dec; 307(11):G1130-43. PubMed ID: 25277800 [TBL] [Abstract][Full Text] [Related]
16. Reduced susceptibility to cholesterol gallstone formation in mice that do not produce apolipoprotein B48 in the intestine. Wang HH; Wang DQ Hepatology; 2005 Oct; 42(4):894-904. PubMed ID: 16175613 [TBL] [Abstract][Full Text] [Related]